From Biomarker to Bedside: Integrated Care as the Real Innovation in Alzheimer’s Disease
Open access0 citations
Abstract
For decades, clinicians treating Alzheimer’s disease could offer accurate diagnosis, symptomatic drugs, and compassionate support, but nothing that altered the course of the disease [...]
// Source
View paper (DOI)Open access versionOpenAlexSwiss Archives of Neurology Psychiatry and PsychotherapyPublished 2026-10-12
Authors: Paul Gerson Unschuld
Institutions: University of Geneva, Geneva College